1Epigenetic regulation of the inflammatory response in strokeJingyi Liang，Fei Yang，Zixiao Li，Qian LiReviews3045-3062
2Human induced pluripotent stem cell-derived therapies for regeneration after central nervous system injuryStephen Vidman，Yee Hang Ethan Ma，Nolan Fullenkamp，Giles W.PlantReviews3063-3075
4Targeting capabilities of engineered extracellular vesicles for the treatment of neurological diseasesXinyu Yang，Xiangyu Gao，Xiaofan Jiang，Kangyi Yue，Peng LuoReviews3076-3094
5Exploring the interaction between the gut microbiota and cyclic adenosine monophosphate-protein kinase A signaling pathway:a potential therapeutic approach for neurodegenerative diseasesFengcheng Deng，Dan Yang，Lingxi Qing，Yifei Chen，Jilian Zou，Meiling Jia，Qian Wang，Runda Jiang，Lihua HuangReviews3095-3112
6Understanding the link between type 2 diabetes mellitus and Parkinson's disease:role of brain insulin resistanceTheodora Ntetsika，Sergiu-Bogdan Catrina，Ioanna MarkakiReviews3113-3123
8Copper homeostasis and neurodegenerative diseasesYuanyuan Wang，Daidi Li，Kaifei Xu，Guoqing Wang，Feng ZhangReviews3124-3143
9Temporal dynamics of neonatal hypoxic-ischemic encephalopathy injuries on magnetic resonance imagingHolly Flyger，Samantha J.Holdsworth，Alistair J.Gunn，Laura Bennet，Hamid AbbasiReviews3144-3150
10Advances in therapies using mesenchymal stem cells and their exosomes for treatment of peripheral nerve injury:state of the art and future perspectivesFatima Aldali，Chunchu Deng，Mingbo Nie，Hong ChenReviews3151-3171
11A systematic review of progenitor survival and maturation in Parkinsonian modelsGiulia Comini，Eilís DowdReviews3172-3178
12Oligodendroglial heterogeneity in health,disease,and recovery:deeper insights into myelin dynamicsPieter-Jan Serneels，Julie D.De Schutter，Lies De Groef，Lieve Moons，Steven BergmansReviews3179-3192
13Induced pluripotent stem cell-related approaches to generate dopaminergic neurons for Parkinson's diseaseLing-Xiao Yi，Hui Ren Woon，Genevieve Saw，Li Zeng，Eng King Tan，Zhi Dong ZhouReviews3193-3206
14Iron-handling solute carrier SLC22A17 as a blood-brain barrier target after strokeXueqi Ren，Wenlu LiPerspectives3207-3208
15Reassessing the AMPK-MTORC1 balance in autophagy in the central nervous systemMarta García-Juan，Mario Villa，Irene Benito-Cuesta，Lara Ordóñez-Gutiérrez，Francisco WandosellPerspectives3209-3210
16The complex role of protocadherin-19 in brain function:a focus on the oxytocin systemSara Mazzoleni，Marta Busnelli，Silvia BassaniPerspectives3211-3212
17Vagus nerve stimulation in intracerebral hemorrhage:the need for further researchSheharyar S.Baig，Ali N.Ali，Arshad MajidPerspectives3213-3214
18Inspires effective alternatives to backpropagation:predictive coding helps understand and build learningZhenghua Xu，Miao Yu，Yuhang SongPerspectives3215-3216
19Beginning from the end:the presynaptic terminal as a pathomechanism hub in frontotemporal dementia and amyotrophic lateral sclerosisLaura Huggon，Emma L.ClaytonPerspectives3217-3218
20Misfolded amyloid-beta conformational variants(strains)as drivers of Alzheimer's disease neuropathologySalvatore Saieva，Rodrigo MoralesPerspectives3219-3220
